anatera stungulyf, lausn 10 %
alcon nordic a/s - fluoresceinum natríum - stungulyf, lausn - 10 %
emla (emla) lyfjaplástur 25+25 mg/plástur
aspen pharma trading limited - lidocainum inn; prilocainum inn - lyfjaplástur - 25+25 mg/plástur
emla (emla) krem 25+25 mg/g
aspen pharma trading limited - lidocainum inn; prilocainum inn - krem - 25+25 mg/g
bactroban smyrsli 20 mg/g
glaxosmithkline pharma a/s - mupirocinum inn - smyrsli - 20 mg/g
hepcludex
gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - veirueyðandi lyf til almennrar notkunar - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - Æxlishemjandi lyf - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
fluconazol krka hart hylki 150 mg
krka sverige ab - fluconazolum inn - hart hylki - 150 mg
diflucan mixtúruduft, lausn 10 mg/ml
pfizer aps - fluconazolum inn - mixtúruduft, lausn - 10 mg/ml
fluconazol krka hart hylki 200 mg
krka sverige ab - fluconazolum inn - hart hylki - 200 mg
fluconazol krka hart hylki 50 mg
krka sverige ab - fluconazolum inn - hart hylki - 50 mg